POINT Biopharma Global

$8.83 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About POINT Biopharma Global

POINT Biopharma Global Inc. operates as a clinical-stage global pharmaceutical company. The Company focuses on the development and commercialization of radioligand therapies for the treatment of cancer. POINT Biopharma Global serves customers worldwide.

Stock Analysis

last close $8.11
1-mo return 1.1%
3-mo return 44.8%
avg daily vol. 435.95T
52-week high 11.72
52-week low 4.25
market cap. $735M
forward pe -
annual div. -
roe -42.2%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 45.2%

Subscribe now for daily local and international financial news